Moderna Inc. said its experimental flu shot met its goal in a late-stage trial, clearing the path for its broader strategy of selling combination vaccines.

The mRNA drug developer said it will begin discussing approval with the FDA, which has adopted stricter vaccine review ...

An influenza vaccine candidate from Moderna showed promising results in a late-stage trial, bringing the drug maker one step ...

Reported symptoms of NB.1.8.1 are similar to other COVID-19 strains, but one distinctive complaint is a severe sore throat, ...

Legislative changes in states like Maine and Colorado aim to protect vaccine access and adapt to federal policy shifts ...

Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...

As fired and retired scientists rallied outside in the Atlanta heat, an advisory panel that Robert F. Kennedy Jr. handpicked ...

an RSV vaccine to guard against respiratory syncytial virus, annual flu shots and all recommended COVID-19 vaccinations. Some older people are really eager to be vaccinated. Robin Wolaner, 71, a ...

For decades, international researchers have received a small slice of the National Institutes of Health budget. In 2024, out ...

As international research projects are upended, European leaders say they will fill the funding void. Is that realistic?

Sen. Bill Cassidy, the Republican from Louisiana, is also a doctor. He put up resistance last February to Donald Trump’s choice to ...

It’s a question laid to rest years ago, as studies showed no evidence that the preservative causes any health problems.